Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

(2012) A. H. Diacon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

(2012) Maria Tarcela Gler et al.   NEW ENGLAND JOURNAL OF MEDICINE

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

(2011) D. Falzon et al.   EUROPEAN RESPIRATORY JOURNAL

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

(2010) José A Caminero et al.   LANCET INFECTIOUS DISEASES

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

(2009) Evan W Orenstein et al.   LANCET INFECTIOUS DISEASES

Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis

(2009) James C. Johnston et al.   PLoS One

Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant Tuberculosis

(2008) Doh Hyung Kim et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Treatment Outcomes for HIV‐Uninfected Patients with Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis

(2008) Yong Soo Kwon et al.   CLINICAL INFECTIOUS DISEASES

Extensively Drug‐Resistant Tuberculosis in California, 1993–2006

(2008) Ritu Banerjee et al.   CLINICAL INFECTIOUS DISEASES

Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study

(2008) Philly O'Riordan et al.   PLoS One